Visualizing RNAi at Work
News Jul 06, 2015
The phenomenon of RNAi is expected to find applications in medical treatments. RNAi is mediated by RNA-induced silencing complex (RISC), which contains a small RNA and an Argonaute protein at its core and cleaves the target RNA. However, there were no suitable tools to directly monitor the RNAi reaction and its molecular mechanism by which RISC cleaves the target RNA has remained unclear.
Now, a research group at the University of Tokyo (Professor Takuya Ueda, Professor Yukihide Tomari, Researcher Chunyan Yao and Research Associate Hiroshi M Sasaki,) and at Kyoto University (Researcher Hisashi Tadakuma), has developed a single-molecule imaging assay for observing target RNA cleavage by RISC in a test tube in real time for the first time, showing how RISC accurately cleaves and releases targets. Specifically, their obsercations provide direct evidence for the model that the small RNA in the RISC consists of two parts, one of which quickly binds to the target RNA to be cleaved, while the other proofreads that the correct RNA has been found.
This groundbreaking result reveals RISC’s molecular mechanism of action and the illustration of this process was adopted as the cover design of this issue of the journal. This achievement will also contribute to accelerating the research applications of RNAi such as to the development of RNA-based next-generation drugs, for example as gene therapy to suppress the production of a disease-causing protein.
Children who are genetically predisposed to overweight, due to common gene variants, can still lose weight by changing their diet and exercise habits. Around 750 children and adolescents with overweight or obesity undergoing lifestyle intervention participated in the study conducted by researchers from the University of Copenhagen and Holbæk Hospital.